semaglutide nash phase 3 for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers ESSENCE Phase 3 trial results – A Placebo-Controlled Trial of Subcutaneous
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























